DOI:
10.1055/s-00033101
Neurology International Open
LinksClose Window
References
Schwartzbach CJ, Grove RA, Brown R. et al.
Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: A randomised, single-blind, phase II study.
J Neurol 2017;
264: 304-315
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.